Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
This study has been completed.
Sponsor:
Resverlogix Corp
Information provided by:
Resverlogix Corp
ClinicalTrials.gov Identifier:
NCT00768274
First received: October 7, 2008
Last updated: January 27, 2010
Last verified: January 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |